Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

NCT05767359

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

NCT04151667

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: H. Lee Moffitt Cancer & Research Institute Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

NCT00492050

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

PICAROS - Acalabrutinib RWE on 1L CLL in Spain

NCT05999877

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Research Site Almería, Andalusia, Spain

Research Site Córdoba, Andalusia, Spain

Research Site Granada, Andalusia, Spain

Research Site Jaén, Andalusia, Spain

View all 47 locations

View Trial Details

Active, Not Recruiting

Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy

NCT06049134

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

NCT02194387

Conditions: Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +61 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

NCT02446457

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

NCT03336333

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Augusta University Augusta, Georgia, United States

Northwestern University Chicago, Illinois, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Research Medical Center Kansas City, Missouri, United States

View all 158 locations

View Trial Details

Active, Not Recruiting

Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD

NCT06636487

Conditions: Asthma Bronchiale, Bronchial Diseases, Bronchiectasis, +14 more
Locations: Copenhagen University Center, Amager Copenhagen, Greater Copenhagen, Denmark

Copenhagen University Center, Frederiksberg-Bispebjerg Copenhagen, Greater Copenhagen, Denmark

Copenhagen University Center, Hvidovre Copenhagen, Greater Copenhagen, Denmark

Copenhagen University Center, Herlev-Gentofte Gentofte Municipality, Greater Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

NCT05502250

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: BE-Bruxelles-STLUC Brussels, Belgium

DK-Aarhus N-AUH Aarhus, Denmark

DK-Copenhagen-RIGSHOSPITALET Copenhagen, Denmark

DK-Odense-OUH Odense, Denmark

View all 15 locations

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions